Clinical Trials
64 trialsObservational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Corin
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
N-Power Medicine
PROVIDENCE
AstraZeneca
A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd.
Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland
Pfizer
RESONATE
Novartis
TavieSkin
Pierre Fabre Medicament
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Pfizer
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
EchoTip AcuCore Post-Market Clinical Study
Cook Group Incorporated
GS_ZKM
Gene Solutions
START
Lyell Immunopharma, Inc.
Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination
Adaptimmune
INGA
Bristol-Myers Squibb
Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling
Immatics US, Inc.
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
Viome
FINN
Bristol-Myers Squibb
Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of Treatment
Daiichi Sankyo
Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
Dynamic Light
OSPREY
OncoSil Medical Limited
StivargaPMS
Bayer
HOMING
Angle plc
Treat ER+ight
Novartis
This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.
Repertoire Immune Medicines
RECORD
Terumo Europe N.V.
Poseidon
iOMEDICO AG
Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study
Bristol-Myers Squibb
VOLUME-PRO
Bristol-Myers Squibb
A Study of Treatment Patterns and Clinical Outcomes in First Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (1L R/M SCCHN) Participants in Europe
Bristol-Myers Squibb
Post-Marketing Surveillance of Lenvima in Korean Patients
Eisai Inc.
NEPTUN
iOMEDICO AG
CHAPLIN
iOMEDICO AG
Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
D1 Medical Technology (Shanghai) Co., Ltd, China
HER-Seq: A Blood-based Screening Study to Identify Patients With HER2 Mutations for Enrollment Into Clinical Research Studies of Neratinib
Puma Biotechnology, Inc.
Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors
Adaptimmune
PIONEER
SpeciCare
PROXie
iOMEDICO AG
REVEAL
AstraZeneca
Establishment of a PDT Patient Registry
Concordia Laboratories Inc.
COSMiC
Janssen Inc.
RENACALL
Pfizer
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
Foundation Medicine
BioPATH
GlaxoSmithKline
A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Genentech, Inc.
CERAM
Stryker Trauma and Extremities
FMI Registry
Foundation Medicine
Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer
Janssen Diagnostics, LLC
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Janssen Diagnostics, LLC
GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study
Janssen Diagnostics, LLC
In Vitro Functional Modulation of Monocyte-derived Dendritic Cells of Patients With Cancer by Peptides
Recepta Biopharma